Analyst Conference Summaries

Biotechnology Investor Aids

Cidara Therapeutics

conference date: August 9, 2022 press release only.

Coverage of Cidara conferences has not yet begun, though I started buying the stock in March 2021.

Cidara Therapeutics: Rezafungin Data Could Bring Value [Seeking Alpha, July 20, 2021]

Cidara Therapeutics Q1 2022 Press Release Cidara Therapeutics Q2 2022 Press Release    
May 11, 2022 Aug. 9, 2022    
Cidara Therapeutics Q1 2021 Press Release Cidara Therapeutics Q2 2021 Press Release Cidara Therapeutics Q3 2021 Press Release Cidara Therapeutics Q4 2021 Press Release
May 13, 2021 Aug. 12, 2021 Nov. 10, 2021 March 7, 2022

Cidara Therapeutics (CDTX) is a clinical-stage biotechnology company specializing in therapies for viral and fungal infections.

Cidara Therapeutics web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers